CorVel (NASDAQ:CRVL) Rating Increased to Buy at StockNews.com

CorVel (NASDAQ:CRVL - Get Free Report) was upgraded by investment analysts at StockNews.com from a "hold" rating to a "buy" rating in a research note issued to investors on Monday.

CorVel Price Performance

Shares of NASDAQ:CRVL traded down $1.88 during mid-day trading on Monday, hitting $117.25. The company had a trading volume of 26,254 shares, compared to its average volume of 101,689. The firm has a fifty day moving average price of $123.64 and a 200 day moving average price of $112.98. The company has a market capitalization of $5.98 billion, a PE ratio of 68.97 and a beta of 1.16. CorVel has a one year low of $76.20 and a one year high of $128.61.

CorVel (NASDAQ:CRVL - Get Free Report) last released its quarterly earnings data on Tuesday, February 4th. The business services provider reported $0.46 earnings per share for the quarter. CorVel had a net margin of 10.12% and a return on equity of 32.22%.

Insider Buying and Selling at CorVel

In other CorVel news, Director Steven J. Hamerslag sold 10,000 shares of the business's stock in a transaction on Thursday, February 6th. The shares were sold at an average price of $123.48, for a total transaction of $1,234,800.00. Following the completion of the sale, the director now owns 314,000 shares in the company, valued at approximately $38,772,720. The trade was a 3.09 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CFO Brandon O'brien sold 1,523 shares of the business's stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $119.56, for a total transaction of $182,089.88. Following the sale, the chief financial officer now owns 17,142 shares of the company's stock, valued at $2,049,497.52. This trade represents a 8.16 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 12,573 shares of company stock worth $1,541,962. 47.57% of the stock is owned by corporate insiders.

Institutional Trading of CorVel

A number of hedge funds and other institutional investors have recently bought and sold shares of CRVL. Kayne Anderson Rudnick Investment Management LLC grew its stake in shares of CorVel by 193.7% in the 4th quarter. Kayne Anderson Rudnick Investment Management LLC now owns 5,714,351 shares of the business services provider's stock worth $635,779,000 after acquiring an additional 3,768,440 shares in the last quarter. Vanguard Group Inc. grew its stake in shares of CorVel by 202.1% in the 4th quarter. Vanguard Group Inc. now owns 3,281,649 shares of the business services provider's stock worth $365,116,000 after acquiring an additional 2,195,466 shares in the last quarter. Renaissance Technologies LLC grew its stake in shares of CorVel by 184.1% in the 4th quarter. Renaissance Technologies LLC now owns 1,858,830 shares of the business services provider's stock worth $206,813,000 after acquiring an additional 1,204,611 shares in the last quarter. Dimensional Fund Advisors LP grew its stake in shares of CorVel by 187.3% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,545,619 shares of the business services provider's stock worth $171,969,000 after acquiring an additional 1,007,651 shares in the last quarter. Finally, Neuberger Berman Group LLC grew its stake in shares of CorVel by 204.6% in the 4th quarter. Neuberger Berman Group LLC now owns 845,531 shares of the business services provider's stock worth $94,074,000 after acquiring an additional 567,984 shares in the last quarter. Institutional investors own 51.36% of the company's stock.

CorVel Company Profile

CorVel Corporation provides workers' compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.